全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 152645-33-5 | 5-Methyl-2-nitrophenyl isocyanate | C8H6N2O3 |
| 152670-41-2 | N,N'-Di(1-naphthyl)-4,4'-benzidine | C32H24N2 |
| 152673-32-0 | 2-Methyl-2-Propanyl (2S,4S)-4-Amino-2-Methyl-1-Pyrrolidinecarboxylate;(2S,4S)-tert-butyl 4-amino-2-methylpyrrolidine-1-carboxylate | C10H20N2O2 |
| 152684-26-9 | 5-Bromo-3-methoxy-2-nitro-pyridine;3-Bromo-5-methoxy-6-nitropyridine | C6H5BrN2O3 |
| 152684-30-5 | 5-Bromo-2-methoxy-3-nitropyridine | C6H5BrN2O3 |
| 152699-63-3 | Dibenzyl 5-Aminoisophthalate;1,3-Benze<wbr>nedicarbo<wbr>xylicacid<wbr>,5-amino-<wbr>,1,3-bis(<wbr>phenylmet<wbr>hyl)ester;5-Aminobenzene-1,3-dicarboxylic acid dibenzyl ester;5-Aminoisophthalic acid dibenzyl ester | C22H19NO4 |
| 152708-24-2 | Valsartan azide impurity;5-[2-[4-(azidomethyl)phenyl]phenyl]-2H-tetrazole | C14H11N7 |
| 152763-53-6 | Thulium tris[bis(trimethylsilyl)amide];Thulium(3+) bis(trimethylsilyl)amide | 3(C6H18NSi2).Tm |
| 152766-94-4 | N-[2-(1H-Indol-3-Yl)Ethyl]Tetracosanamide;N-[2-(1H-indol-3-yl)ethyl]tetracosanamide;N-Lignoceroyltryptamine;tetracosanamide, N-[2-(1H-indol-3-yl)ethyl]- | C34H58N2O |
| 152775-45-6 | 3,5-Dimethyl-4-methoxybenzonitrile;4-Methoxy-3,5-dimethylbenzonitrile | C10H11NO |
| 152784-32-2 | 4-(2,4-Dihydroxyphenyl)-5-[(4-hydroxyphenyl)methyl]-2(5H)-furanone | C17H14O5 |
| 152803-24-2 | 5-Hydroxynicotinonitrile;3-Cyano-5-hydroxypyridine | C6H4N2O |
| 152807-26-6 | 3-(4'-Fluorobenzoyl)indole | C15H10FNO |
| 152810-27-0 | 8-MethylaMino-5--nitroquinoline | |
| 152811-62-6 | Piboserod;N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide; SB 207266 | C22H31N3O2 |
| 152812-42-5 | Methyl 2-chloroindole-3-carboxylate | C10H8ClNO2 |
| 152814-23-8 | 5-AMinoisoquinoline, HCl | |
| 152814-25-0 | 3-Fluoro-N-Methylaniline, HCl | |
| 152820-13-8 | Ethyl 4-Chloro-1-Piperidinecarboxylate;Ethyl 4-Chloro-1-piperidinecarboxylate | C8H14ClNO2 |
| 152831-97-5 | Ethyl 4-Cyano-2-Oxobutanoate;Ethyl 4-cyano-2-oxobutyrate;MFCD01319626 | C7H9NO3 |
| 152840-65-8 | 2,6-Dichloro-5-fluoro-3-pyridinamine;3-Amino-2,6-dichloro-5-fluoropyridine | C5H3Cl2FN2 |
| 152840-71-6 | 1-Bromo-3-chloro-2,4,5-trifluorobenzene | C6HBrClF3 |
| 152840-81-8 | (1-<Sup>13</Sup>C)Valine;DL-Valine-1-13C;485594_ALDRICH | C413CH11NO2 |
| 152842-93-8 | 2-(Allyloxy)-5-Chlorobenzaldehyde;2-(Allyloxy)-5-chlorobenzenecarbaldehyde;5-chloro-2-(prop-2-en-1-yloxy)benzaldehyde;5-chloro-2-prop-2-enyloxybenzaldehyde | C10H9ClO2 |
| 152854-19-8 | 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-pyridine (2R,3R)-2,3-dihydroxybutanedioate (1:1);Xanomeline tartrate | C14H23N3OS .C4H6O6 |
| 152864-32-9 | Europium(3+) Ethanedioate Hydrate (2:3:1);Europium(III) oxalate hydrate;574228_ALDRICH | C6H2Eu2O13 |
| 152894-10-5 | N,N-Bis(pentafluoroethanesulphonyl)imide | C4HF10NO4S2 |
| 152914-73-3 | 2,2-Difluoro-2-[1,1,2,2-Tetrafluoro-2-(1,1,2,2,3,3,4,4,4-Nonafluorobutoxy)Ethoxy]-Ethanol;FLUORINATED DIETHYLENEGLYCOL MONOBUTYL ETHER;1H,1H-PERFLUORO-3,6-DIOXADECAN-1-OL | C8H3F15O3 |
| 152915-83-8 | B-[6-(Phenylmethoxy)-2-Naphthalenyl]-Boronic Acid;6-BENZYLOXYNAPHTHALENE-2-BORONIC ACID;6-Benzyloxy-2-Naphthaleneboronic Acid;6-(BENZYLOXY)-2-NAPHTHYLBORONIC ACID | C17H15BO3 |
| 152918-18-8 | N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide;1-Deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-beta-D-ribofuranuronamide; CF 101; IB-MECA | C18H19IN6O4 |
| 152918-26-8 | (2S,3S,4R,5R)-5-{6-[(4-Aminobenzyl)Amino]-9H-Purin-9-Yl}-3,4-Dihydroxy-N-Methyltetrahydro-2-Furancarboxamide;AB-MECA;N6-(4-Ami<wbr>nobenzyl)<wbr>-9-[5-(me<wbr>thylcarbo<wbr>nyl)-β-D-<wbr>ribofuran<wbr>osyl]aden<wbr>ine;N6-(4-Aminobenzyl)-N-methylcarboxamidoadenosine | C18H21N7O4 |
| 152918-27-9 | (2S,3S,4R,5R)-5-{6-[(4-Amino-3-Iodobenzyl)Amino]-9H-Purin-9-Yl}-3,4-Dihydroxy-N-Methyltetrahydro-2-Furancarboxamide;(2S,3S,4R<wbr>,5R)-5-(6<wbr>-{[(4-ami<wbr>no-3-iodo<wbr>phenyl)me<wbr>thyl]amin<wbr>o}-9H-pur<wbr>in-9-yl)-<wbr>3,4-dihyd<wbr>roxy-N-me<wbr>thyloxola<wbr>ne-2-carb<wbr>oxamide;(2S,3S,4R<wbr>,5R)-5-{6<wbr>-[(4-amin<wbr>o-3-iodob<wbr>enzyl)ami<wbr>no]-9H-pu<wbr>rin-9-yl}<wbr>-3,4-dihy<wbr>droxy-N-m<wbr>ethyltetr<wbr>ahydrofur<wbr>an-2-carb<wbr>oxamide;1-[6-[[(4<wbr>-Amino-3-<wbr>iodopheny<wbr>l)methyl]<wbr>amino]-9H<wbr>-purin-9-<wbr>yl]-1-deo<wbr>xy-N-meth<wbr>yl-β-D-ri<wbr>bofuranur<wbr>onamide | C18H20IN7O4 |
| 152922-71-9 | 1-(Hydroxymethyl)cyclopropaneacetonitrile | C6H9NO |
| 152922-73-1 | Methyl 1-(Mercaptomethyl)cyclopropaneacetate | C7H12O2S |
| 152937-04-7 | 2-Bromo-6-fluorobenzothiazole | C7H3BrFNS |
| 152943-33-4 | Bupropion USP Related Compound C;1-(3-Chlorophenyl)-2-hydroxypropan-1-one | C9H9ClO2 |
| 152946-68-4 | Nolatrexed dihydrochloride;3,4-Dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride | C14H12N4OS.2(HCl) |
| 152955-68-5 | 1-Benzylpyrrolo[2,3-b]Pyridine;1-Benzylpyrrolo[2,3-b]pyridine;1H-Pyrrolo[2,3-b]pyridine, 1-(phenylmethyl)-;MFCD09834870 | C14H12N2 |
| 152957-34-1 | 2-Nitrophenyl 2-(acetylamino)-2-deoxy-beta-D-galactopyranoside | C14H18N2O8 |
| 152992-58-0 | Ethyl 5-aMino-4-cyano-1-p-tolylpyrazole-3-carboxylate | |
| 153004-31-0 | (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol | C32H47F5O2S |
| 153012-08-9 | 2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate | C19H16F2O6 |
| 153025-29-7 | 6-Chloro-2-(1-Piperazinyl)-1,3-Benzothiazole;1-(6-Chloro-1,3-benzothiazol-2-yl)piperazine;6-Chloro-2-(piperazin-1-yl)-1,3-benzothiazole 95%+;6-Chloro-2-piperazin-1-yl-1,3-benzothiazole | C11H12ClN3S |
| 153034-78-7 | 2-Fluoro-3-iodo-5-methylpyridine;2-Fluoro-3-iodo-5-picoline | C6H5FIN |
| 153034-80-1 | 2-Fluoro-4-iodo-3-methylpyridine | C6H5FIN |
| 153034-82-3 | 2-Fluoro-4-iodopyridine-3-carboxaldehyde;2-Fluoro-4-iodonicotinaldehyde | C6H3FINO |
| 153034-83-4 | 2-Fluoro-3,4-diiodopyridine | C5H2FI2N |
| 153034-86-7 | 2-Chloro-4-iodopyridine | C5H3ClIN |
| 153034-88-9 | 2-Chloro-4-iodo-3-methylpyridine;2-Chloro-4-iodo-3-picoline | C6H5ClIN |
| 153034-90-3 | 2-Chloro-4-iodopyridine-3-carboxaldehyde;2-Chloro-4-iodonicotinaldehyde | C6H3ClINO |